Risk factors of osteoporosis in post-gastrectomy gastric cancer patients: a systematic review and meta-analysis
Related Experiment Video
Updated: Jun 10, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Yici Yan1, Lulin Yu1, Xinyu Cai1
1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310000, Zhejiang, China.
Abstract:
Osteoporosis is a highly prevalent and serious complication among long-term survivors of gastric cancer (GC) after gastrectomy. However, the key risk factors predisposing patients to this condition have not been systematically assessed. PubMed, EMBASE, Cochrane Library, and Web of Science databases were searched for observational studies from inception until July 21, 2025, to collect data on the risk factors for osteoporosis. Two independent reviewers appraised the methodological quality using the Newcastle-Ottawa Scale. Fixed-effects and random-effects models were used to calculate the odds ratio (OR) and 95% confidence interval (CI) for each factor. Eleven studies (covering 232,814 subjects) that reported clear associations were included in the analysis, the following risk factors were associated with osteoporosis in post-gastrectomy GC patients: female sex (number of studies [n] = 6; OR: 2.30, 95% CI: 1.50-3.51, p < 0.001), older age (n = 4; OR: 1.06, 95% CI: 1.03-1.09, p < 0.001), diabetes mellitus (n = 5; OR: 1.16, 95% CI: 1.07-1.25, p < 0.001), anemia (n = 2; OR: 2.20, 95% CI: 1.51-3.19, p < 0.001), elevated alkaline phosphatase (ALP) (n = 2; OR: 3.51, 95% CI: 1.35-9.12, p = 0.010), and Charlson Comorbidity Index score (CCI) > 3 (n = 2; OR: 1.24, 95% CI: 1.08-1.41, p = 0.002). Urban residence was associated with a modest protective effect (n = 2; HR: 0.87, 95% CI: 0.78-0.97, p = 0.013).
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Osteoclasts in Bone Remodeling
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
